A comprehensive view of Ear / Nose / Throat Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron's ongoing trial of gene therapy DB-OTO for genetic deafness yields promising results, with two children showing significant improvement in hearing; the therapy targets variants of the otoferlin gene causing congenital deafness
Published: May 10, 2024 by Biopharm International
Acclarent receives first and only FDA clearance for new treatment alternative for children needing repeat ear tubes
Published: December 20, 2023 by Biosense Webster Inc.
Haleon and Aptar Pharma launch Otrivin Nasal Mist, a new generation nasal spray with microdroplet technology for greater comfort and ease of use for treating nasal congestion; the product will first be available in Poland, Greece and Portugal
Published: October 23, 2023 by Haleon plc
Olympus named exclusive distributor of Vathin E-SteriScope single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic ENT procedures; product is manufactured by Hunan Vathin Medical Instrument Co
Published: September 18, 2023 by Olympus America Inc.
Regeneron to acquire clinical-stage biotechnology firm Decibel Therapeutics for US$109M; the two firms have been collaborating since 2017 and are developing three gene therapy programs targeting different forms of congenital, monogenic hearing loss
Published: August 11, 2023 by Regeneron Pharmaceuticals Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count